Inventor
CUI SHENG
US17 patents
⚠️ This page may combine multiple inventors who share the name “CUI SHENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
9 patentsUS9988354B2Jun 5, 2018
Salt of omecamtiv mecarbil and process for preparing salt
AMGEN INC24 citations95
US11472773B2Oct 18, 2022
Salt of omecamtiv mecarbil and process for preparing salt
AMGEN INC17 citations92
US11465969B2Oct 11, 2022
Salts and crystal forms of omecamtiv mecarbil
AMGEN INC16 citations90
US11926592B2Mar 12, 2024
Salts and crystal forms of omecamtiv mecarbil
AMGEN INC8 citations82
US10407464B2Sep 10, 2019
Method for preparing AMG 416
AMGEN INC2 citations68
US11377474B2Jul 5, 2022
Method for preparing AMG 416 (etelcalcetide)
AMGEN INC0 citations57
US12441741B2Oct 14, 2025
Ring closing synthesis of macrocyclic MCL-1 inhibitor intermediates
AMGEN INC0 citations50
US10858389B2Dec 8, 2020
Solution phase method for preparing etelcalcetide
AMGEN INC0 citations45
US11708341B2Jul 25, 2023
Synthesis of (S)-2-amino-4-methyl-((R)-2-methyloxirane-2-yl)-pentan-1-one and pharmaceutically acceptable salts thereof
AMGEN INC0 citations39
CYTOKINETICS INC
3 patentsUS11958809B2Apr 16, 2024
Salt of omecamtiv mecarbil and process for preparing salt
CYTOKINETICS INC10 citations92
US12221417B2Feb 11, 2025
Salt of omecamtiv mecarbil and process for preparing salt
CYTOKINETICS INC2 citations83
US12583821B2Mar 24, 2026
Salt of omecamtiv mecarbil and process for preparing salt
CYTOKINETICS INC0 citations60
NEWAMSTERDAM PHARMA B V
3 patentsUS12006305B2Jun 11, 2024
Salts of obicetrapib and processes for their manufacture and intermediates thereof
NEWAMSTERDAM PHARMA B V5 citations80
US12570628B2Mar 10, 2026
Salts of obicetrapib and processes for their manufacture and intermediates thereof
NEWAMSTERDAM PHARMA B V0 citations56
US12378221B2Aug 5, 2025
Salts of obicetrapib and processes for their manufacture and intermediates thereof
NEWAMSTERDAM PHARMA B V0 citations55